MATTEELLI, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 19.147
AS - Asia 9.009
EU - Europa 5.514
SA - Sud America 2.157
Continente sconosciuto - Info sul continente non disponibili 498
AF - Africa 310
OC - Oceania 53
Totale 36.688
Nazione #
US - Stati Uniti d'America 18.801
SG - Singapore 3.220
CN - Cina 2.534
BR - Brasile 1.806
UA - Ucraina 1.446
HK - Hong Kong 1.086
IT - Italia 963
DE - Germania 773
VN - Vietnam 666
GB - Regno Unito 460
FR - Francia 404
TR - Turchia 390
FI - Finlandia 378
RU - Federazione Russa 333
IE - Irlanda 324
IN - India 302
BD - Bangladesh 250
CA - Canada 160
ZA - Sudafrica 146
AR - Argentina 130
MX - Messico 107
IQ - Iraq 98
PK - Pakistan 81
SE - Svezia 80
ID - Indonesia 71
EC - Ecuador 59
AT - Austria 56
ES - Italia 54
CO - Colombia 53
NL - Olanda 50
PL - Polonia 46
JP - Giappone 44
SA - Arabia Saudita 41
AU - Australia 33
UZ - Uzbekistan 31
BE - Belgio 28
KE - Kenya 26
MA - Marocco 25
PY - Paraguay 23
MY - Malesia 22
VE - Venezuela 22
CL - Cile 21
NZ - Nuova Zelanda 20
AE - Emirati Arabi Uniti 19
JM - Giamaica 17
PE - Perù 16
RO - Romania 16
CZ - Repubblica Ceca 15
UY - Uruguay 15
EG - Egitto 14
IR - Iran 13
TN - Tunisia 13
DZ - Algeria 12
JO - Giordania 12
KZ - Kazakistan 12
LT - Lituania 12
NP - Nepal 12
OM - Oman 12
ET - Etiopia 11
IL - Israele 11
AZ - Azerbaigian 10
BG - Bulgaria 10
PH - Filippine 10
AL - Albania 9
GH - Ghana 9
NG - Nigeria 9
CH - Svizzera 8
CR - Costa Rica 8
HN - Honduras 8
LB - Libano 8
TT - Trinidad e Tobago 8
TW - Taiwan 8
TZ - Tanzania 8
DK - Danimarca 7
DO - Repubblica Dominicana 7
EU - Europa 7
MU - Mauritius 7
RS - Serbia 7
AM - Armenia 6
GT - Guatemala 6
GY - Guiana 6
PT - Portogallo 6
BB - Barbados 5
HU - Ungheria 5
PS - Palestinian Territory 5
UG - Uganda 5
BO - Bolivia 4
CI - Costa d'Avorio 4
CY - Cipro 4
KH - Cambogia 4
KR - Corea 4
NI - Nicaragua 4
NO - Norvegia 4
PA - Panama 4
QA - Qatar 4
SK - Slovacchia (Repubblica Slovacca) 4
BH - Bahrain 3
BY - Bielorussia 3
KG - Kirghizistan 3
SN - Senegal 3
Totale 36.139
Città #
Fairfield 2.323
Singapore 1.731
Ashburn 1.585
Woodbridge 1.582
Houston 1.225
Hong Kong 1.069
Jacksonville 1.069
Seattle 953
Wilmington 834
Cambridge 828
Chandler 760
Princeton 604
Ann Arbor 603
The Dalles 574
San Jose 563
Beijing 533
New York 484
Dublin 325
Nanjing 307
Los Angeles 305
Istanbul 303
Lauterbourg 301
Ho Chi Minh City 255
Helsinki 240
Council Bluffs 209
São Paulo 166
Columbus 156
Des Moines 151
Brescia 148
San Diego 138
Moscow 137
Hanoi 135
Buffalo 127
Munich 123
Dearborn 117
Nanchang 112
Redondo Beach 109
Santa Clara 107
Chicago 100
Milan 100
Dallas 95
Changsha 93
Shanghai 84
Shenyang 83
San Francisco 80
London 76
Nuremberg 76
Tianjin 69
Orem 65
Hebei 64
Jinan 62
Rio de Janeiro 56
Jiaxing 54
Rome 53
Chennai 46
Johannesburg 46
Atlanta 44
Belo Horizonte 43
Frankfurt am Main 43
New Delhi 41
Tokyo 39
Toronto 39
Brooklyn 38
Warsaw 38
Montreal 36
Kocaeli 35
Manchester 35
Mexico City 35
Baghdad 33
Stockholm 33
Brasília 31
Denver 31
Turku 30
Tashkent 29
Brussels 28
Curitiba 28
Guangzhou 28
Hangzhou 28
Haiphong 26
Kunming 26
Cape Town 25
Da Nang 25
Ningbo 25
Amsterdam 24
Messina 24
Norwalk 24
Phoenix 24
Poplar 24
Verona 24
Vienna 24
Guayaquil 22
Quito 22
Lancaster 21
Lanzhou 21
Lahore 20
Riyadh 20
Salt Lake City 20
Zhengzhou 20
Boardman 19
Boston 19
Totale 23.857
Nome #
Treatment of TB 496
Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infection in adolescents in Northern Italy: an observational school-based study. 314
WHO strategies for the programmatic management of drug-resistant tuberculosis 290
Impact of the SARS Coronavirus 2 epidemic on tuberculosis treatment outcome, Northern Italy 235
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 208
Towards tuberculosis elimination: An action framework for low-incidence countries 207
Treatment patterns and associated costs for genital warts in Italy 204
Efficacy and tolerability of topical 1% cidofovir cream for the treatment of external anogenital warts in HIV-infected persons 201
Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: Different methodology and settings, same results 197
Tuberculosis-related mortality in people living with HIV in Europe and Latin America: An international cohort study 188
Rediscovering high technology from the past: Thoracic surgery is back on track for multidrug-resistant tuberculosis 184
Imported malaria in an HIV-positive traveler. A case-report with a fatal outcome 183
Contact investigation based on serial interferon-gamma release assays (IGRA) in children from the hematology-oncology ward after exposure to a patient with pulmonary tuberculosis. 178
Screening for active and latent tuberculosis among asylum seekers in Italy: A retrospective cohort analysis 175
Active tuberculosis case finding among pregnant women: A pilot project in Burkina Faso 175
Malaria and anaemia in pregnant women in urban Zanzibar, Tanzania. 172
Louse-borne relapsing fever in a refugee from Mali 172
Chlamydia trachomatis genotypes in school adolescents, Italy 168
Screening for Chlamydia trachomatis and Neisseria gonorrhoeae among high-school participants using the Versant CT/GC DNA 1.0 assay (kinetic PCR). 167
Advances in the treatment of malaria 166
Tuberculosis: epidemiology and control 166
Global tuberculosis prevention: Should we start from the beginning? 165
Crossborder travel and multidrugresistant tuberculosis (MDRTB) in Europe 159
Imported malaria in northern italy: Epidemiology and clinical features observed over 18 years in the teaching hospital of Brescia 158
A Strange Manifestation of Malaria in a Native Nigerian Boy 156
Evolving treatment implementation among HIV- infected pregnant women and their partners: Results from a national surveillance study in Italy, 2001-2015 156
Tuberculosis elimination and the challenge of latent tuberculosis 152
The cascade of care in diagnosis and treatment of latent tuberculosis infection: A systematic review and meta-analysis 151
Comparison of effectiveness and safety of imipenem/clavulanate-versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB 151
Identification of the skin virome in a boy with widespread human papillomavirus-2-positive warts that completely regressed after administration of tetravalent human papillomavirus vaccine 151
STI epidemics in the Indian Ocean Region: can the phase be assessed? 150
Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy 150
Fatal disseminated toxoplasmosis during primary HIV infection. 149
Risk assessment of tuberculosis in immunocompromised patients: A TBNET study 148
New Antituberculosis Drugs: From Clinical Trial to Programmatic Use 148
Changing antimicrobial resistance profiles among Neisseria gonorrhoeae isolates in Italy, 2003 to 2012 148
Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials 147
Building a European database to gather multi-country evidence on active and latent TB screening for migrants 147
App-based symptoms screening with Xpert MTB/RIF Ultra assay used for active tuberculosis detection in migrants at point of arrivals in Italy: The E-DETECT TB intervention analysis 147
Respiratory syndrome and respiratory tract infections in foreign-born and national travelers hospitalized with fever in Italy 147
New italian guidelines for malaria prophylaxis in travellers to endemic areas 146
Latent Mycobacterium tuberculosis infection 146
A scoping review of cost-effectiveness of screening and treatment for latent tuberculosis infection in migrants from high-incidence countries 146
Latent tuberculous infection: Ethical considerations in formulating public health policy 146
Extensively drug-resistant tuberculosis: Epidemiology and management 146
Viral Load and Risk of Tuberculosis in HIV Infection 145
Mycobacterium sherrisii pulmonary disease, Burkina Faso 145
The Holy Grail of prevention of sexually transmitted infections in travellers 144
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study 144
Travel-associated sexually transmitted infections: An observational cross-sectional study of the GeoSentinel surveillance database 143
Recent developments in the diagnosis and management of tuberculosis 143
Xpert MTB/RIF as add-on test to microscopy in a low tuberculosis incidence setting 143
VAGINAL COLONIZATION WITH CANDIDA SPP IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED WOMEN: A COHORT STUDY 142
Travel-associated sexually transmitted infections: an observational cross-sectional study of the GeoSentinel surveillance database 142
An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease 142
Differences in BCG vaccination and tuberculin skin-test positivity 141
Sentinel surveillance of imported dengue via travellers to Europe 2012 to 2014: Tropnet data from the denguetools research initiative 141
Effectiveness and safety of meropenem/ clavulanate-containing regimens in the treatment of MDR- and XDR-TB 140
Breaking the barriers: Migrants and tuberculosis 140
Recommendations for the diagnosis of pediatric tuberculosis 140
Systemic exposure to rifampicin in patients with tuberculosis and advanced HIV disease during highly active antiretroviral therapy in Burkina Faso 138
Prevalence of anti-poliovirus type 1, 2 and 3 antibodies in unvaccinated Italian travelers 137
Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis 137
Assessing the impact of defining a global priority research agenda to address HIV-associated tuberculosis 137
Baggage Malaria in Italy: Cryptic Malaria explained? 136
In reply. Promoting ethical and evidence-based policies for latent tuberculosis 136
Advancing global programmatic management of latent tuberculosis infection for at risk populations 134
Continuous isoniazid for the treatment of latent tuberculosis infection in people living with HIV 134
Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area 134
Prevalence and incidence of syphilis among South American transgender sex workers in Northern Italy 134
Multidisciplinary approach to prostatitis 134
Compassionate and optimum use of new tuberculosis drugs 133
Effectiveness and cost-effectiveness of screening migrants for active tuberculosis and latent tuberculous infection 133
The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: A systematic review 133
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report 133
Disseminated Mycobacterium genavense infection after immunosuppressive therapy shows underlying new composite heterozygous mutations of β1 subunit of IL-12 receptor gene. 132
Socioeconomic status and biomedical risk factors in migrants and native tuberculosis patients in Italy 132
Strongyloides stercoralis infection: an underlying cause of invasive bacterial infections of enteric origin. Results from a prospective cross-sectional study of a northern Italian tertiary hospital 132
Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis 131
Supervised preventive therapy for latent tuberculosis infection in illegal immigrants in Italy 130
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network 130
An epidemiological survey of vulvovaginal candidiasis in Italy 130
Immune Responses to SARS-CoV-2 Infection and Vaccine in a Big Italian COVID-19 Hospital: An 18-Month Follow-Up 130
Recommendations Concerning the Therapeutic Approach to Immunocompromised Children with Tuberculosis 128
Multiple-dose pharmacokinetics of efavirenz with and without the use of rifampicin in HIV-positive patients. 127
Exogenous reinfection of tuberculosis in a low-burden area 127
Antiretroviral Therapy in HIV Infected Children with Tuberculosis: A Systematic Review 127
Treatment optimization in patients co-infected with HIV and Mycobacterium tuberculosis infections: Focus on drug-drug interactions with rifamycins 127
Ripped from the headlines: How can we harness communications to control TB? 127
Recrudescence of Plasmodium falciparum malaria in a primigravidae woman with anemia as the only sign of diseases: a case report 127
Acute respiratory distress syndrome in Plasmodium vivax malaria in traveler returning from Venezuela. 126
Genetic Resistance Determinants for Cefixime and Molecular Analysis of Gonococci Isolated in Italy 126
The Italian registry of pulmonary non-tuberculous mycobacteria - IRENE: The study protocol 126
Recommendations for treating children with drug-resistant tuberculosis 126
INDAGINE SU CONSUMI DI ALCOOL, COMPORTAMENTI SESSUALI E INFEZIONI SESSUALMENTE TRASMESSE NELLA POPOLAZIONE ADOLESCENTE DELLA PROVINCIA DI BRESCIA 125
Epidemiological features and case-management practices of imported malaria in northern Italy 125
Prevalence and distribution of soil-transmitted helminth (STH) infections in urban and indigenous schoolchildren in Ortigueira, State of Paranà, Brasil: implications for control 125
Mycobacterium decipiens sp. nov., a new species closely related to the Mycobacterium tuberculosis complex 124
Paradoxical reaction during tuberculosis treatment in HIV-seronegative patients [9] 124
Molecular analysis of tetracycline-resistant gonococci: rapid detection of resistant genotypes using a real-time PCR assay 123
Totale 15.401
Categoria #
all - tutte 202.306
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 202.306


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.016 0 423 59 110 13 129 133 181 101 244 178 445
2022/20232.179 346 47 24 211 175 578 1 222 358 18 91 108
2023/20242.088 124 64 110 144 80 387 74 89 575 26 43 372
2024/20255.033 40 22 54 551 691 480 372 153 501 467 1.115 587
2025/202610.869 1.071 1.577 897 1.765 987 612 1.466 425 593 852 372 252
2026/2027679 398 281 0 0 0 0 0 0 0 0 0 0
Totale 36.688